Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein VI. Suppression of adoptively transferred disease and differential effects of oral vs. intravenous tolerization

Journal of Neuroimmunology

Volumn 46, Issue 1-2, 1993, Pages 73-82

  Miller, Ariel ^a   Jenny Zhang, Z ^a   Sobel, Raymond A ^b   Al Sabbagh, Ahmad ^a   Weiner, Howard L ^a  

^a Boston University Medical Campus   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Experimental autoimmune encephalomyelitis; Myelin basic protein; Oral tolerance

Indexed keywords

MYELIN BASIC PROTEIN;

ADOPTIVE TRANSFER; ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; DRUG THERAPY; FEMALE; IMMUNOLOGICAL TOLERANCE; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT;

ADMINISTRATION, ORAL; AMINO ACID SEQUENCE; ANIMAL; ANTIGENS, CD8; AUTOANTIGENS; ENCEPHALOMYELITIS, EXPERIMENTAL AUTOIMMUNE; FEMALE; HYPERSENSITIVITY, DELAYED; IMMUNE TOLERANCE; IMMUNIZATION, PASSIVE; IMMUNOTHERAPY; INJECTIONS, INTRAVENOUS; MOLECULAR SEQUENCE DATA; MYELIN BASIC PROTEINS; RATS; RATS, INBRED LEW; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; T-LYMPHOCYTE SUBSETS;

EID: 0027488091     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/0165-5728(93)90235-Q     Document Type: Article

References (42)

1. Suppression of PLP induced EAE in SJL mice by oral administration of MBP
2. The rapid isolation of clonable antigen-specific T lymphocyte lines capable of mediating autoimmune encephalomyelitis
3. Suppression of experimental autoimmune encephalomyelitis by the oral administration of myelin basic protein
4. Suppression of chronic relapsing experimental autoimmune encephalomyelitis by oral administration of myelin antigens
5. In vivo role of interleukin 4 in T cell tolerance induced by agneous protein antigen
6. + T lymphocytes and monocytes
7. Large scale preparation of myelin basic protein from central nervous tissue of several mammalian species
8. Antigens as immunoregulators
9. Infectious immunological tolerance
10. Oral but not intravenous alloantigen prevents accelerated allograft rejection by selective intragraft TH2 cell activation
11. Suppression of experimental allergic encephalomyelitis by oral administration of myelin basic protein and its fragments
12. T-cell tolerance by clonal elimination in the thymus
13. + suppressor cells inhibit the function of effector cells of experimental autoimmune encephalomyelitis through a mechanism involving transforming growth factor-beta
14. Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with down-regulation of inflammatory cytokines and differential upregulation of TGF-β, IL-4 and PGE expression in the brain
15. + thymocytes
16. + T lymphocytes
17. Testing of autoimmune therapy begins
18. Immunologic suppression after oral administration of antigen. I. Specific suppressor cells formed in rat Peyer's patches after oral administration of sheep erytrocytes and their systemic migration
19. Alterations in T cell antigen specificity and class II restriction during the course of chronic relapsing experimental allergic encephalomyelitis
20. Direct evidence for anergy in T lymphocytes tolerized by oral administration of ovalbumin
21. The role of digestive enzymes in orally induced immune tolerance
22. Inhibition of specific immune response by feeding protein antigens. IV. Evidence for tolerance and specific active suppression of cell mediated immune response to ovalbumin
23. Tolerance and suppressor mechanisms in experimental autoimmune encephalomyelitis: Implications for immunotherapy of human autoimmune diseases
24. Antigen driven bystander suppression following oral administration of antigens
25. Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of TGF-β following antigen specific triggering
26. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. V. Hierarchy of suppression elicitated by myelin basic protein from different species
27. Epitopes of myelin basic protein (MBP) that trigger TGF-β release following oral tolerization to MBP are different from the encephalitogenic epitopes
28. The regulation of immune responses to dietary protein antigens
29. Suppression of type II collagen-induced arthritis by intragastric administration of soluble type II collagen
30. Inhibition of S-antigen induced experimental autoimmune uveoretinitis by oral induction of tolerance with S-antigen
31. T cell receptor peptide therapy triggers autoregulation of experimental encephalomyelitis
32. Kinetics and specificity of T and B cell responses in relapsing experimental autoimmune encephalomyelitis
33. A nondeletional mechanism of thymic self tolerance
34. Down-regulation of the immune response to histocompatability antigens and prevention of sensitization by skin allografts by orally administered alloantigen
35. Acquisition of immunologic self-tolerance
36. The immunopathology of experimental allergic encephalomyelitis. I. Quantitative analysis of inflammatory cells in situ
37. Immunoregulation of experimental autoimmune encephalomyelitis: conditions for induction of suppressor cells and analysis of mechanisms
38. Double-blind pilot trial of oral tolerization with myelin antigens in multiple sclerosis
39. Oral tolerance in experimental autoimmune encephalomyelitis. III. Evidence for clonal anergy
40. Suppression of adjuvant arthritis in Lewis rats by oral administration of type II collagen
41. Suppression of diabetes in NOD mice by oral administration of porcine insulin